All products
By area
By ATC classifier
! Pharmacovigilance

QUANIL solution

The active substance:


Indications for use:

Stroke, acute phase disorders of cerebral circulation and treatment of complications and the consequences of stroke. 

Traumatic brain injury and its neurological consequences.

Cognitive impairment and behavioral disorders, resulting from chronic diseases and degenerative brain disorders. 

1 ml of solution contains citicoline sodium equivalent to citicoline 100 mg;

excipients:sorbitol solution (Е 420), glycerin, methyl parahydroxybenzoate sodium (Е 219), propyl parahydroxybenzoate sodium (Е 217), propylene glycol, sodium citrate, sodium saccharin, potassium sorbate, strawberry flavor, anhydrous citric acid, purified water.

For detailed information, please see instruction for medical use.